Results 261 to 270 of about 4,782 (272)

Real-world evidence with extrafine single-inhaler triple therapy in asthma: the TriMaximize study

Pneumologie, 2022
C Geßner, B Akyildiz, K Cesarz, A Sauer, V Bogoevska, C P Criée   +5 more
openaire   +1 more source

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2016
Dave Singh, Alberto Papi, Massimo Corrádi   +2 more
exaly  

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

Lancet, The, 2019
J Christian Virchow, Piotr Kuna, Pierluigi Paggiaro   +2 more
exaly  

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2017
Jørgen Vestbo, Alberto Papi, Massimo Corrádi   +2 more
exaly  

Safety of two single-inhaler triple therapies compared

Reactions Weekly
openaire   +1 more source

Comorbidities and their association with exacerbations in single inhaler triple therapy COPD patients

Minerva Respiratory Medicine
SPOSATO, Bruno, SPOSATO, Lorenzo, LACERENZA, Leonardo G., PETRUCCI, Elisa, CRESTI, Alberto, BARATTA, Pasquale, SERAFINI, Andrea, MICHELETTO, Claudio, RICCI, Alberto, SCALESE, Marco   +9 more
openaire   +1 more source

Single inhaler extra fine triple therapy versus open triple therapy in COPD: TRIPOLI observational study

Airway pharmacology and treatment
Javier López, Daniel Vega, Mercedes Segura, Esther Sánchez, Eva Cabrera, José Luis Velasco   +5 more
openaire   +1 more source

Association of Incident Pneumonia and Exacerbations with Extrafine Triple Therapy in One Single Inhaler in COPD

Pneumologie, 2018
M Scuri, J Vestbo, A Papi, M Corradi, M Spinola, I Montagna, C Francisco, G Cohuet, S Vezzoli, A Muraro, S Petruzzelli, D Singh   +11 more
openaire   +1 more source

Effectiveness of Single Versus Multiple Inhaler Triple Therapy on Mortality and Cardiopulmonary Risk Reduction in COPD: The SKOPOS-MAZI Study

American Journal of Medicine
Michael Pollack, Eleni Rapsomaniki, Antonio Anzueto   +2 more
exaly  

Is single-inhaler triple therapy cost-effective versus multiple-inhaler triple therapy for COPD in Germany? The INTREPID trial

Airway pharmacology and treatment
Stephen G Noorduyn, Kai-Michael Beeh, Dhvani Shah, Alan Martin, Robyn Kendall, Priyadarsini Dasari, Afisi S Ismaila, Jing Claussen   +7 more
openaire   +1 more source